This injectable hyaluronic acid gel is developed for applications involving atrophic, depressed, and localized contour-deficient scars. The product is engineered for professional aesthetic and medical use where precise placement of an HA gel is required to improve the appearance of depressed tissue contours.
Unlike a general-purpose facial filler page, this product focuses on a specific application: atrophic and depressed scar correction. Product selection can be configured according to HA concentration, gel characteristics, injection requirements, syringe format, and target-market specifications.
Technical Specifications
|
Parameter |
Specification Details |
|
Product Name |
Hyaluronic Acid Atrophic Scar Filler |
|
Material |
Hyaluronic Acid (HA) |
|
Product Form |
Sterile Injectable Gel |
|
Intended Application |
Atrophic / Depressed Scar Correction |
|
HA Concentration |
Confirmed per product specification |
|
Cross-Linking |
Confirmed per product specification |
|
Gel Characteristics |
Confirmed per product specification |
|
Rheological Parameters |
Confirmed per product specification |
|
Syringe Volume |
1 mL (Standard / Customizable) |
|
Syringe Material |
Medical-grade glass / Confirmed |
|
Needle / Cannula |
Confirmed per SKU requirement |
|
Sterilization |
Confirmed per medical device standards |
|
Shelf Life |
Confirmed per stability testing data |
|
Storage Condition |
Confirmed per product documentation |
|
Packaging |
Primary blister, secondary carton / Confirmed |
|
Regulatory Status |
Market-specific; documentation available upon request |
Key Product Characteristics
Hyaluronic Acid-Based Injectable Gel: The filler utilizes hyaluronic acid as its primary injectable biomaterial, recognized for its water-binding characteristics and established use in soft-tissue applications.
Application-Specific Positioning: Positioned directly for atrophic and depressed scar applications rather than general facial filler usage, enabling distributors to develop a focused product offering for scar correction.
Controlled Gel Properties: Physical and rheological characteristics directly affect extrusion force, handling, and tissue behavior. Procurement and product qualification rely on measurable formulation metrics rather than descriptive claims.
Sterile Pre-Filled Presentation: Supplied in a pre-filled syringe configuration. Syringe volume, connector configuration, needle or cannula option, and packaging format are confirmed for each specific SKU prior to production.
Intended Application
Atrophic Scars
The primary application is the correction of visible depressions associated with atrophic scars. Depending on scar morphology, anatomical location, and clinical assessment, professional users evaluate the product for localized depressed contours where an injectable HA gel is clinically appropriate.
Depressed Scar Contours
The product is positioned for localized contour irregularities associated with depressed scar tissue. Product selection takes into account scar depth, treatment area, injection technique, and the physical properties of the selected HA formulation.
Localized Soft-Tissue Depression
For applications involving localized tissue depression, the appropriate HA formulation is selected according to the intended injection plane, product rheology, and clinical requirements. Final indication and injection technique must follow approved labeling and applicable regulations in the destination market.
How to Select the Right HA Scar Filler
HA Concentration: Evaluated alongside cross-linking, gel structure, and rheological properties rather than as a standalone indicator of product performance.
Cross-Linking: Affects the internal structure and stability of the HA gel. Buyers should request formulation specifications and supporting quality documentation.
Rheological Profile: Storage modulus (G'), loss modulus (G''), viscosity, and other measurable values provide a reliable basis for comparing injectable gels.
Injection Characteristics: Extrusion force and injection behavior affect handling during professional use, requiring needle gauge and syringe design to be evaluated in tandem.
Product Format: Key procurement considerations include syringe volume, syringe material, needle or cannula configuration, secondary packaging, labeling, sterile barrier system, lot identification, and expiration-date format.
Manufacturing and Quality Control
Manufacturing integrates R&D, medical biomaterial synthesis, and injectable product production. Operations utilize dedicated R&D laboratories and precision filling equipment within a medical-device quality management framework.
Quality control covers the complete production chain:
Raw material qualification and HA material identification
Formulation control, homogenization, and filling
Sterile processing and packaging integrity verification
Finished-product inspection and batch traceability
Microbiological, sterility, and physicochemical testing
Packaging, labeling, and release documentation verification
OEM and Private Label Options
Customized supply projects are supported for partners developing proprietary aesthetic injectable product lines:
Product Configuration: HA concentration, syringe volume, needle/cannula configuration, and secondary packaging presentation.
Private Label: Brand name, custom logo, label design, packaging artwork, and market-specific labeling compliance.
Packaging Solutions: Primary blister packs, secondary folding cartons, instruction leaflets, localized language printing, and standardized batch/expiry-date formatting.
FAQ
Q: What is a Hyaluronic Acid Atrophic Scar Filler?
A: It is an injectable HA gel positioned for professional applications involving atrophic, depressed, or localized scar-related tissue contours.
Q: Is this the same as a conventional HA dermal filler?
A: Not necessarily. Although both products utilize hyaluronic acid, formulation parameters, rheological properties, intended use, and regulatory positioning differ according to clinical requirements.
Q: What HA concentration is available?
A: The available HA concentration depends on the specific product formulation. Detailed technical specifications can be provided upon direct inquiry.
Q: Can the product be supplied under a private label?
A: Yes. OEM and private-label configurations are evaluated based on product specifications, packaging requirements, minimum order quantities (MOQ), and target-market regulations.
Q: Can the syringe and packaging be customized?
A: Packaging, labeling, and syringe-related configurations can be customized according to the selected product specification and regulatory compliance needs.
Q: Can you provide samples before bulk production?
A: Sample availability is confirmed based on the selected formulation and project requirements.
Q: What documents are available for product evaluation?
A: Documentation packages include product specifications, COAs, quality documentation, labeling materials, and applicable regulatory documents depending on the destination market.
Hot Tags: hyaluronic acid atrophic scar filler, China hyaluronic acid atrophic scar filler manufacturers, suppliers, factory
